These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218 [TBL] [Abstract][Full Text] [Related]
27. Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions. Eser G; Karabacakoglu A; Karakose S; Eser C; Kayacetin E World J Gastroenterol; 2006 Mar; 12(10):1603-6. PubMed ID: 16570354 [TBL] [Abstract][Full Text] [Related]
28. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings. Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855 [TBL] [Abstract][Full Text] [Related]
30. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis. Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563 [TBL] [Abstract][Full Text] [Related]
31. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867 [TBL] [Abstract][Full Text] [Related]
32. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248 [TBL] [Abstract][Full Text] [Related]
33. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579 [TBL] [Abstract][Full Text] [Related]
34. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Schima W; Függer R Eur Radiol; 2002 Dec; 12(12):2998-3008. PubMed ID: 12439582 [TBL] [Abstract][Full Text] [Related]
36. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks]. Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779 [TBL] [Abstract][Full Text] [Related]
38. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Bartolozzi C; Donati F; Cioni D; Crocetti L; Lencioni R Eur Radiol; 2000; 10(11):1697-702. PubMed ID: 11097390 [TBL] [Abstract][Full Text] [Related]
39. MRI of the pancreas: tumours and tumour-simulating processes. Schima W Cancer Imaging; 2006 Dec; 6(1):199-203. PubMed ID: 17208676 [TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. Sahani DV; O'Malley ME; Bhat S; Hahn PF; Saini S J Comput Assist Tomogr; 2002; 26(2):216-22. PubMed ID: 11884777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]